Panion & Bf Biotech (TPE:1760) Cyclically Adjusted Book per Share: NT$21.23 (As of Dec. 2025)


TPE:1760 Panion & Bf Biotech Inc TPE:1760
74 GF Score
Price NT$62.20
GF Value NT$96.02
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Panion & Bf Biotech Cyclically Adjusted Book per Share?

Panion & Bf Biotech TPE:1760 -2.66% 74 Cyclically Adjusted Book per Share is NT$21.23 as of Dec. 2025. GuruFocus rates TPE:1760 with a GF Score™ of 74/100 and a GF Value™ of NT$96.02 (Significantly Undervalued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Panion & Bf Biotech's adjusted book value per share for the three months ended in Dec. 2025 was NT$22.798. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is NT$21.23 for the trailing ten years ended in Dec. 2025.

During the past 12 months, Panion & Bf Biotech's average Cyclically Adjusted Book Growth Rate was 7.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-07-09), Panion & Bf Biotech's current stock price is NT$62.20. Panion & Bf Biotech's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2025 was NT$21.23. Panion & Bf Biotech's Cyclically Adjusted PB Ratio of today is 2.93.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Panion & Bf Biotech was 10.98. The lowest was 2.81. And the median was 4.52.


Panion & Bf Biotech  (TPE:1760) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Panion & Bf Biotech's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=62.20/21.23
=2.93

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Panion & Bf Biotech was 10.98. The lowest was 2.81. And the median was 4.52.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Panion & Bf Biotech Cyclically Adjusted Book per Share Related Terms


Panion & Bf Biotech Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Panion & Bf Biotech's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Panion & Bf Biotech Cyclically Adjusted Book per Share Chart

Panion & Bf Biotech Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 17.70 19.84 21.23

Panion & Bf Biotech Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.84 20.31 20.69 21.04 21.23

TPE:1760 vs VRTX, REGN, ALNY: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Panion & Bf Biotech's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Panion & Bf Biotech Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Panion & Bf Biotech's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Panion & Bf Biotech's Cyclically Adjusted PB Ratio falls into.


TPE:1760
74GF Score
Panion & Bf Biotech Inc TPE:1760
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Panion & Bf Biotech Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Panion & Bf Biotech's adjusted Book Value per Share data for the three months ended in Dec. 2025 was:

Adj_Book= Book Value per Share /CPI of Dec. 2025 (Change)*Current CPI (Dec. 2025)
=22.798/324.0540*324.0540
=22.798

Current CPI (Dec. 2025) = 324.0540.

Panion & Bf Biotech Quarterly Data

Book Value per Share CPI Adj_Book
201512 11.223 236.525 15.376
201606 10.632 241.018 14.295
201609 0.000 241.428 0.000
201612 11.662 241.432 15.653
201703 0.000 243.801 0.000
201706 11.463 244.955 15.165
201709 11.869 246.819 15.583
201712 12.080 246.524 15.879
201803 16.962 249.554 22.026
201806 16.005 251.989 20.582
201809 16.198 252.439 20.793
201812 17.342 251.233 22.369
201903 17.947 254.202 22.879
201906 16.727 256.143 21.162
201909 16.807 256.759 21.212
201912 17.459 256.974 22.016
202003 15.736 258.115 19.756
202006 15.458 257.797 19.431
202009 15.451 260.280 19.237
202012 15.923 260.474 19.810
202103 14.960 264.877 18.302
202106 15.853 271.696 18.908
202109 22.576 274.310 26.670
202112 22.545 278.802 26.204
202203 21.647 287.504 24.399
202206 23.533 296.311 25.736
202209 24.545 296.808 26.798
202212 23.410 296.797 25.560
202303 21.670 301.836 23.265
202306 21.852 305.109 23.209
202309 22.026 307.789 23.190
202312 22.290 306.746 23.548
202403 21.363 312.332 22.165
202406 21.616 314.175 22.296
202409 21.940 315.301 22.549
202412 22.419 315.605 23.019
202503 20.975 319.799 21.254
202506 21.238 322.561 21.336
202509 22.183 324.800 22.132
202512 22.798 324.054 22.798

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of NT$21.23 mean?
Panion & Bf Biotech (TPE:1760) has a Cyclically Adjusted Book per Share of NT$21.23 as of Dec. 2025. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Panion & Bf Biotech and its competitors.
Is Panion & Bf Biotech's Cyclically Adjusted Book per Share too high?
Panion & Bf Biotech's current Cyclically Adjusted Book per Share is NT$21.23. Overall, Panion & Bf Biotech has a GF Score™ of 74/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Panion & Bf Biotech's Cyclically Adjusted Book per Share compare to VRTX and REGN?
Panion & Bf Biotech's Cyclically Adjusted Book per Share of NT$21.23 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Panion & Bf Biotech and its competitors. Panion & Bf Biotech's current Cyclically Adjusted Book per Share is NT$21.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Panion & Bf Biotech stock overvalued right now?
Based on GuruFocus' analysis, Panion & Bf Biotech (TPE:1760) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$96.02, compared to a current price of NT$62.20 — trading 35.2% below its estimated fair value. The current Cyclically Adjusted Book per Share is NT$21.23. Panion & Bf Biotech's overall GF Score™ is 74/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Panion & Bf Biotech (TPE:1760), the current Cyclically Adjusted Book per Share is NT$21.23 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Panion & Bf Biotech (TPE:1760) Overvalued in 2026?

Based on GuruFocus' analysis, Panion & Bf Biotech stock appears to be undervalued. The current stock price of NT$62.20 is trading 35.2% below its estimated GF Value™ of NT$96.02. GuruFocus considers Panion & Bf Biotech to be Significantly Undervalued.

Key valuation signals for TPE:1760:

  • Cyclically Adjusted Book per Share: NT$21.23
  • GF Value™: NT$96.02 vs. price of NT$62.20 (35.2% below fair value)
  • GF Score™: 74/100 with 4 warning signs

No single metric tells the full story. See the TPE:1760 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Panion & Bf Biotech Business Description

Address No. 3, Park Street, 16th Floor, Nangang District, Taipei, TWN, 11503
Panion & Bf Biotech Inc operates as a biotech and pharmaceutical company. The company, along with its subsidiaries, is mainly engaged in the manufacture and sales of pharmaceutical, cosmeceutical, diagnostic, medical device, and active pharmaceutical ingredients. It has four core business groups: disease treatment, disease prevention, disease diagnosis, and delayed aging. It has geographic segments in Taiwan; China, Hong Kong, and Macau; the USA; and Korea. It generates a majority of its revenue from the Taiwan segment. Product-wise the firm generates the majority of its revenue from Pharmaceutical products.
74GF Score

Get the complete analysis for TPE:1760

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$62.20
Price
NT$96.02
GF Value